BioMarin Pharmaceutical, Inc. (BMRN)
55.97
+0.38
(+0.68%)
USD |
NASDAQ |
Mar 26, 13:35
BioMarin Pharmaceutical Market Cap : 10.76B for March 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.529B |
| Ionis Pharmaceuticals, Inc. | 12.45B |
| Mirum Pharmaceuticals, Inc. | 5.456B |
| MannKind Corp. | 725.58M |
| Terns Pharmaceuticals, Inc. | 4.760B |
Market Cap Related Metrics
| PE Ratio | 31.41 |
| PS Ratio | 3.357 |
| Price to Book Value | 1.768 |
| Price to Free Cash Flow | 15.18 |
| Price | 55.97 |
| Earnings Yield | 3.18% |
| Operating PE Ratio | 13.32 |
| Normalized PE Ratio | 17.57 |